KRAS and neoplasm: Our recent study demonstrated for the first time an inverse correlation between the expression levels of RBM5, and transforming growth factor alpha (TGF-α) signaling factors, EGFR, and KRAS in NSCLC tissues[22], which suggested that the presence of a complex regulatory network between those genes was involved in tumor suppression and oncogenic expression.